Phase II study of pegylated liposomal doxorubicin HCI (caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small cell lung cancer
| Autor: | Leighl, Natasha B., Goss, Glenwood D., Lopez, Pedro, Burkes, Ronald L., Dancey, Janet E., Rahim, Yasmin H., Rudinskas, Leona C., Rodgers, Angela, Pond, Gregory R., Shepherd, Frances A. |
|---|---|
| Zdroj: | In Lung Cancer 2003 41 Supplement 2:S232-S232 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect